Abstract
The increasing age of the population around the world has meant that greater attention is being paid to disorders that mainly affect older people. In particular, work is focusing on ways to preserve the healthy brain and prevent dementia. Preventive studies are complex and must take into account not only simple approaches such as those used in risk and outcome studies, but also stage of life, survival and mortality, and population context before their effect can be assessed. This paper presents questions and areas which must be explored if the potential for prevention of dementia during brain ageing is to be properly understood.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Assessing cognitive decline in the aging brain: lessons from rodent and human studies
npj Aging Open Access 19 October 2023
-
Distinct components of cardiovascular health are linked with age-related differences in cognitive abilities
Scientific Reports Open Access 18 January 2023
-
Autologous skin-derived neural precursor cell therapy reverses canine Alzheimer dementia-like syndrome in a proof of concept veterinary trial
Stem Cell Research & Therapy Open Access 17 June 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Report of the World Health Organization. Active ageing: a policy framework. Aging Male 5, 1–37 (2002).
BBC News[online] (2006).
Pope, S. K., Shue, V. M. & Beck, C. Will a healthy lifestyle help prevent Alzheimer's disease? Annu. Rev. Public Health 24, 111–132 (2003).
Jansson, E. T. Alzheimer disease is substantially preventable in the United States — review of risk factors, therapy, and the prospects for an expert software system. Med. Hypotheses 64, 960–967 (2005).
Chapman, D. P., Williams, S. M., Strine, T. W., Anda, R. F. & Moore, M. J. Dementia and its implications for public health. Prev. Chronic. Dis. 3, A34 (2006).
Jedrziewski, M. K., Lee, V. M. -Y. & Trojanowski, J. Q. Lowering the risk of Alzheimer's disease: evidence-based practices emerge from new research. Alzheimers Dement. 1, 152–160 (2005).
Haan, M. N. & Wallace, R. Can dementia be prevented? Brain aging in a population-based context. Annu. Rev. Public Health 25, 1–24 (2004).
Cukierman, T., Gerstein, H. C. & Williamson, J. D. Cognitive decline and dementia in diabetes — systematic overview of prospective observational studies. Diabetologia 48, 2460–2469 (2005).
World Population Prospects 1950–2050. UN Publications (2001).
Ferri, C. P. et al. Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112–2117 (2005).
Brayne, C., Matthews, F. E., McGee, M. A. & Jagger, C. Health and ill-health in the older population in England and Wales. The Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Age Ageing 30, 53–62 (2001).
Manton, K. G., Corder, L. S. & Stallard, E. Estimates of change in chronic disability and institutional incidence and prevalence rates in the U.S. elderly population from the 1982, 1984, and 1989 National Long Term Care Survey. J. Gerontol. 48, S153–S166 (1993).
Manton, K. C., Gu, X. L. & Ukraintseva, S. V. Declining prevalence of dementia in the U.S. elderly population. Adv. Gerontol. 16, 30–37 (2005).
Parker, C. J., Morgan, K. & Dewey, M. E. Physical illness and disability among elderly people in England and Wales: the Medical Research Council Cognitive Function and Ageing Study. The Analysis Group. J. Epidemiol. Community Health 51, 494–501 (1997).
Nilsson, B. O. et al. Morbidity does not influence the T-cell immune risk phenotype in the elderly: findings in the Swedish NONA Immune Study using sample selection protocols. Mech. Ageing Dev. 124, 469–476 (2003).
Williams, J. G., Huppert, F. A., Matthews, F. E. & Nickson, J. Performance and normative values of a concise neuropsychological test (CAMCOG) in an elderly population sample. Int. J. Geriatr. Psychiatry 18, 631–644 (2003).
Keller, J. N. Age-related neuropathology, cognitive decline, and Alzheimer's disease. Ageing Res. Rev. 5, 1–13 (2006).
Whalley, L. J., Deary, I. J., Appleton, C. L. & Starr, J. M. Cognitive reserve and the neurobiology of cognitive aging. Ageing Res. Rev. 3, 369–382 (2004).
Bugg, J. M., Zook, N. A., Delosh, E. L., Davalos, D. B. & Davis, H. P. Age differences in fluid intelligence: contributions of general slowing and frontal decline. Brain Cogn. 62, 9–16 (2006).
Johnson, W. & Gottesman, I. I. Clarifying process versus structure in human intelligence: Stop talking about fluid and crystallized. Behav. Brain Sci. 29, 136–137 (2006).
Baltes, P. B. The aging mind: potential and limits. Gerontologist 33, 580–594 (1993).
Hedden, T. & Gabrieli, J. D. Healthy and pathological processes in adult development: new evidence from neuroimaging of the aging brain. Curr. Opin. Neurol. 18, 740–747 (2005).
Thal, D. R., Del, T. K. & Braak, H. Neurodegeneration in normal brain aging and disease. Sci. Aging Knowledge Environ. 2004, e26 (2004).
Brayne, C. et al. Incidence of clinically diagnosed subtypes of dementia in an elderly population. Cambridge Project for Later Life. Br. J. Psychiatry 167, 255–262 (1995).
Blair, M., Kertesz, A., McMonagle, P., Davidson, W. & Bodi, N. Quantitative and qualitative analyses of clock drawing in frontotemporal dementia and Alzheimer's disease. J. Int. Neuropsychol. Soc. 12, 159–165 (2006).
Harciarek, M. & Jodzio, K. Neuropsychological differences between frontotemporal dementia and Alzheimer's disease: a review. Neuropsychol. Rev. 15, 131–145 (2005).
McKhann, G. et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939–944 (1984).
Mirra, S. S. et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479–486 (1991).
Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C. & Yaffe, K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64, 277–281 (2005).
Honig, L. S., Kukull, W. & Mayeux, R. Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurology 64, 494–500 (2005).
APA. Diagnostic and Statistical Manual of Mental Disorders 3rd edn, revised (American Psychiatric Association, Washington DC, 1987).
Last, J. M. A Dictionary of Epidemiology (Oxford Univ. Press, New York, 2001).
McGee, M. A. & Brayne, C. The impact on prevalence of dementia in the oldest age groups of differential mortality patterns: a deterministic approach. Int. J. Epidemiol. 27, 87–90 (1998).
Murrell, J. R. et al. Association of apolipoprotein E genotype and Alzheimer disease in African Americans. Arch. Neurol. 63, 431–434 (2006).
Gureje, O. et al. APOE ε4 is not associated with Alzheimer's disease in elderly Nigerians. Ann. Neurol. 59, 182–185 (2006).
Brayne, C. Research and Alzheimer's disease: an epidemiological perspective. Psychol. Med. 23, 287–296 (1993).
Brayne, C. Clinicopathological studies of the dementias from an epidemiological viewpoint. Br. J. Psychiatry 162, 439–446 (1993).
Moynihan, R. & Henry, D. The fight against disease mongering: generating knowledge for action. PLoS. Med. 3, e191 (2006).
Bowling, A. & Dieppe, P. What is successful ageing and who should define it? BMJ 331, 1548–1551 (2005).
Whitehouse, P. J., Gaines, A. D., Lindstrom, H. & Graham, J. E. Anthropological contributions to the understanding of age-related cognitive impairment. Lancet Neurol. 4, 320–326 (2005).
Callahan, C. M. & McHorney, C. A. Successful aging and the humility of perspective. Ann. Intern. Med. 139, 389–390 (2003).
Aarsland, D., Zaccai, J. & Brayne, C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord. 20, 1255–1263 (2005).
Honig, L. S. et al. Stroke and the risk of Alzheimer disease. Arch. Neurol. 60, 1707–1712 (2003).
Seshadri, S. et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 37, 345–350 (2006).
Laatikainen, T. et al. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am. J. Epidemiol. 162, 764–773 (2005).
Hebert, R. & Brayne, C. Epidemiology of vascular dementia. Neuroepidemiology 14, 240–257 (1995).
McGuinness, B., Todd, S., Passmore, P. & Bullock, R. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst. Rev. CD004034 (2006).
Ukraintseva, S., Sloan, F., Arbeev, K. & Yashin, A. Increasing rates of dementia at time of declining mortality from stroke. Stroke 37, 1155–1159 (2006).
White, L. et al. Recent clinical–pathologic research on the causes of dementia in late life: update from the Honolulu–Asia Aging Study. J. Geriatr. Psychiatry Neurol. 18, 224–227 (2005).
Boustani, M., Peterson, B., Hanson, L., Harris, R. & Lohr, K. N. Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med. 138, 927–937 (2003).
Wiltfang, J. et al. Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World J. Biol. Psychiatry 6, 69–84 (2005).
Dufouil, C. et al. Population norms for the MMSE in the very old: estimates based on longitudinal data. Mini-Mental State Examination. Neurology 55, 1609–1613 (2000).
Brayne, C. et al. Estimating the true extent of cognitive decline in the old old. J. Am. Geriatr. Soc. 47, 1283–1288 (1999).
Rapp, M. A. & Reischies, F. M. Attention and executive control predict Alzheimer disease in late life: results from the Berlin Aging Study (BASE). Am. J. Geriatr. Psychiatry 13, 134–141 (2005).
Saxton, J. et al. Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset. Neurology 63, 2341–2347 (2004).
Tierney, M. C., Yao, C., Kiss, A. & McDowell, I. Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology 64, 1853–1859 (2005).
Launer, L. J. The epidemiologic study of dementia: a life-long quest? Neurobiol. Aging 26, 335–340 (2005).
Marx, J. Neuroscience. Preventing Alzheimer's: a lifelong commitment? Science 309, 864–866 (2005).
Whincup, P., Cook, D., Papacosta, O. & Walker, M. Birth weight and blood pressure: cross sectional and longitudinal relations in childhood. BMJ 311, 773–776 (1995).
Launer, L. J. et al. Midlife blood pressure and dementia: the Honolulu–Asia aging study. Neurobiol. Aging 21, 49–55 (2000).
Qiu, C., von, S. E., Winblad, B. & Fratiglioni, L. Decline in blood pressure over time and risk of dementia: a longitudinal study from the Kungsholmen project. Stroke 35, 1810–1815 (2004).
Shah, R. C. et al. Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons. Neuroepidemiology 26, 30–36 (2006).
Kuller, L. H. Commentary on 'The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee'. Alzheimers Dement. 2, 33–35 (2006).
Larson, E. B. et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann. Intern. Med. 144, 73–81 (2006).
Rovio, S. et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol. 4, 705–711 (2005).
Kivipelto, M. et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch. Neurol. 62, 1556–1560 (2005).
Heyn, P., Abreu, B. C. & Ottenbacher, K. J. The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch. Phys. Med. Rehabil. 85, 1694–1704 (2004).
Kramer, A. F., Colcombe, S. J., McAuley, E., Scalf, P. E. & Erickson, K. I. Fitness, aging and neurocognitive function. Neurobiol. Aging 26, S124–S127 (2005).
Ioannidis, J. P. Why most published research findings are false. PLoS. Med. 2, e124 (2005).
Saczynski, J. S. et al. The effect of social engagement on incident dementia: the Honolulu–Asia Aging Study. Am. J. Epidemiol. 163, 433–440 (2006).
Verghese, J. et al. Leisure activities and the risk of dementia in the elderly. N. Engl. J. Med. 348, 2508–2516 (2003).
Wilson, R. S. et al. Early life socioeconomic status and late life risk of Alzheimer's disease. Neuroepidemiology 25, 8–14 (2005).
Breteler, M. M. Early life circumstances and late life Alzheimer's disease. Epidemiology 12, 378–379 (2001).
Heyer, C. M. et al. Evaluation of multiple trauma victims with 16-row multidetector CT (MDCT): a time analysis. Rofo 177, 1677–1682 (2005).
Schwammenthal, Y. & Tanne, D. Homocysteine, B-vitamin supplementation, and stroke prevention: from observational to interventional trials. Lancet Neurol. 3, 493–495 (2004).
Mooijaart, S. P. et al. Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study. Am. J. Clin. Nutr. 82, 866–871 (2005).
Elias, M. F. et al. Homocysteine and cognitive performance in the Framingham offspring study: age is important. Am. J. Epidemiol. 162, 644–653 (2005).
Mant, J., McManus, R. J. & Hare, R. Applicability to primary care of national clinical guidelines on blood pressure lowering for people with stroke: cross sectional study. BMJ 332, 635–637 (2006).
Craig, M. C., Maki, P. M. & Murphy, D. G. The Women's Health Initiative Memory Study: findings and implications for treatment. Lancet Neurol. 4, 190–194 (2005).
Kok, H. S. et al. Cognitive function across the life course and the menopausal transition in a British birth cohort. Menopause 13, 19–27 (2006).
de Craen, A. J., Gussekloo, J., Vrijsen, B. & Westendorp, R. G. Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia. Am. J. Epidemiol. 161, 114–120 (2005).
Szekely, C. A. et al. Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 23, 159–169 (2004).
Cherubini, A. et al. Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI study. Neurobiol. Aging 26, 987–994 (2005).
Malouf, R. & Areosa, S. A. Vitamin B12 for cognition. Cochrane Database Syst. Rev. CD004326 (2003).
Zandi, P. P. et al. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Arch. Gen. Psychiatry 62, 217–224 (2005).
Scott, H. D. & Laake, K. Statins for the prevention of Alzheimer's disease. Cochrane Database Syst. Rev. CD003160 (2001).
Barberger-Gateau, P. et al. Correlates of regular fish consumption in French elderly community dwellers: data from the Three-City study. Eur. J. Clin. Nutr. 59, 817–825 (2005).
Espeland, M. A. et al. Association between reported alcohol intake and cognition: results from the Women's Health Initiative Memory Study. Am. J. Epidemiol. 161, 228–238 (2005).
Richards, M. & Wadsworth, M. E. Long term effects of early adversity on cognitive function. Arch. Dis. Child 89, 922–927 (2004).
Richards, M., Shipley, B., Fuhrer, R. & Wadsworth, M. E. Cognitive ability in childhood and cognitive decline in mid-life: longitudinal birth cohort study. BMJ 328, 552 (2004).
Cabeza, R., Anderson, N. D., Locantore, J. K. & McIntosh, A. R. Aging gracefully: compensatory brain activity in high-performing older adults. Neuroimage. 17, 1394–1402 (2002).
Valenzuela, M. J. et al. Memory training alters hippocampal neurochemistry in healthy elderly. Neuroreport 14, 1333–1337 (2003).
Valenzuela, M. J. & Sachdev, P. Brain reserve and dementia: a systematic review. Psychol. Med. 36, 441–454 (2006).
Banks, J., Marmot, M., Oldfield, Z. & Smith, J. P. Disease and disadvantage in the United States and in England. JAMA 295, 2037–2045 (2006).
Matthews, F. & Brayne, C. The incidence of dementia in England and Wales: findings from the five identical sites of the MRC CFA Study. PLoS. Med. 2, e193 (2005).
Cognitive function and dementia in six areas of England and Wales: the distribution of MMSE and prevalence of GMS organicity level in the MRC CFA Study. The Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Psychol. Med. 28, 319–335 (1998).
Dewey, M. E. & Saz, P. Dementia, cognitive impairment and mortality in persons aged 65 and over living in the community: a systematic review of the literature. Int. J. Geriatr. Psychiatry 16, 751–761 (2001).
Guehne, U., Riedel-Heller, S. & Angermeyer, M. C. Mortality in dementia. Neuroepidemiology 25, 153–162 (2005).
McGee, M. A. & Brayne, C. Exploring the impact of prevalence and mortality on incidence of dementia in the oldest old: the sensitivity of a deterministic approach. Neuroepidemiology 20, 221–224 (2001).
Wheeler, J. G., Keavney, B. D., Watkins, H., Collins, R. & Danesh, J. Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet 363, 689–695 (2004).
Jagger, C. et al. Compression or expansion of disability? Forecasting future disability levels under changing patterns of diseases. Kings Fund 1–41 (2006).
Oeppen, J. & Vaupel, J. W. Demography. Broken limits to life expectancy. Science 296, 1029–1031 (2002).
Laukka, E. J., MacDonald, S. W. & Backman, L. Contrasting cognitive trajectories of impending death and preclinical dementia in the very old. Neurology 66, 833–838 (2006).
Lawton, G. The Incredibles. New Sci. 190, 32–38 (2006).
Peto, R. & Doll, R. There is no such thing as aging. BMJ 315, 1030–1032 (1997).
Yip, A. G., Brayne, C. & Matthews, F. E. Risk factors for incident dementia in England and Wales: The Medical Research Council Cognitive Function and Ageing Study. A population-based nested case-control study. Age Ageing 35, 154–160 (2006).
Acknowledgements
With thanks to D. Drachman for a reminder of the phrase 'the elephant in the room' (San Diego, April 2006).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Related links
Related links
DATABASES
OMIM
FURTHER INFORMATION
Rights and permissions
About this article
Cite this article
Brayne, C. The elephant in the room — healthy brains in later life, epidemiology and public health. Nat Rev Neurosci 8, 233–239 (2007). https://doi.org/10.1038/nrn2091
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrn2091
This article is cited by
-
Assessing cognitive decline in the aging brain: lessons from rodent and human studies
npj Aging (2023)
-
Distinct components of cardiovascular health are linked with age-related differences in cognitive abilities
Scientific Reports (2023)
-
Autologous skin-derived neural precursor cell therapy reverses canine Alzheimer dementia-like syndrome in a proof of concept veterinary trial
Stem Cell Research & Therapy (2022)
-
Presence of Geriatric Conditions Is Prognostic of Major Bleeding in Older Patients with Atrial Fibrillation: a Cohort Study
Journal of General Internal Medicine (2022)
-
Restoring metabolism of myeloid cells reverses cognitive decline in ageing
Nature (2021)